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ABSTRAK''
Rinosinusitis kronik adalah penyakit radang kronik yang mengawal proses 
keradangan menyebabkan penghasilan pelbagai sitokin prokeradangan. Faktor 
nekrosis tumor adalah salah satu sitokin prokeradangan yang memainkan peranan 
penting dalam pathogenesis rinosinusitis kronik.  
Kajian kes control ini bertujuan untuk mengenalpasti kewujudan dan perkaitan 
polimorfisma gen TNFα -1031 dan TNFβ +252 di antara rinosinusitis kronik dan 
kontrol yang sihat, seterusnya di antara rinosinusitis kronik yang mempunyai dan 
tidak mempunyai polip hidung. Selain itu, kajian ini ingin menyelidik perkaitan di 
antara gen-gen ini dan factor-faktor berkaitan dengan rinosinusitis kronik. 
Kajian ini melibatkan 48 peserta yang menghidap rinosinusitis kronik yang 
terdiri dari 24 peserta rinosinusitis kronik dengan polip hidung dan 24 peserta 
rinosinusitis kronik tanpa polip hidung, beserta 48 kontrol yang sihat. Sampel ujian 
asid deoksiribonuklik diambil dari mukosa dinding pipi. Seterusnya, kaedah 
mengekstrak gen telah dijalankan pada sampel ini melalui kaedah ‘Polymerase Chain 
Reaction’ dan ‘Restriction Fragment Length Polymorphisms’. Analisis statistik telah 
dilakukan menggunakan ujian ‘Chi-square’ atau ‘Fisher’s exact’ dan ‘multiple logistic 
regression’ untuk menentukan perkaitan polimorfisma gen TNFα -1031 dan TNFβ 
+252 dengan rinosinusitis kronik. 
Kajian ini mengesahkan kewujudan polimorfisma gen TNFα -1031 di mana 
homozigot normal (TT) dan heterozigot mutan (TC) mempunyai pengagihan sama 
rata di antara peserta rinosinusitis kronik dan kontrol serta di antara rinosinusitis 
kronik yang mempunyai dan tidak mempunyai polip hidung. Homozigot mutan (CC) 
tidak wujud dalam populasi kami. Di samping itu, distribusi alel normal (T) dan alel 
! xiv!
mutan (C) juga seimbang. Berkenaan polimorfisma gen TNFβ +252, heterozigot 
mutan (AG) merupakan genotip yang paling banyak dijumpai berbanding homozigot 
normal (AA) dan homozigot mutan (GG). Alel normal (A) dan alel mutan (G) 
mempunyai distribusi yang lebih kurang sama. Analisis mendapati genotip dan alel 
polimorfisma gen TNFα -1031 dan TNFβ +252 tidak menunjukkan perkaitan di 
antara rinosinusitis kronik dan kontrol yang sihat, seterusnya di antara rinosinusitis 
kronik yang mempunyai dan tidak mempunyai polip hidung. Walau bagaimanapun, 
polimorfisma gen TNFα -1031 menunjukkan manfaat signifikan pada peserta 
rinosinusitis kronik yang mempunyai atopi (p-value = 0.037) tetapi tidak pada asma 
dan ketidaktoleransi aspirin. Tiada manfaat signifikan yang diperhatikan di antara 
polimorfisma gen TNFβ +252 dengan faktor-faktor berkaitan rinosinusitis kronik. 
Kesimpulannya, kajian ini menunjukkan kewujudan polimorfisma gen TNFα -
1031 dan TNFβ +252 tidak menunjukkan sebarang manfaat signifikan di antara 
rinosinusitis kronik dan kontrol, seterusnya di antara rinosinusitis kronik yang 
mempunyai dan tidak mempunyai polip hidung. Walaubagaimanapun, kajian ini 
mengusulkan bahawa kewujudan perkaitan di antara polimorfisma gen TNFα -1031 
mempunyai risiko yang lebih tinggi kepada pesakit rinosinusitis kronik yang 
mempunyai atopi.  
!!!!!!!
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ABSTRACT'!
TITLE:! GENETIC! ASSOCIATION! STUDY! OF! TUMOUR! NECROSIS! FACTOR!POLYMORPHISMS! IN!CHRONIC!RHINOSINUSITIS!WITH!AND!WITHOUT!NASAL!POLYPS!
 Chronic rhinosinusitis (CRS) is a chronic inflammatory condition which 
initiates the cascade of inflammatory responses resulting in production of various 
proinflammatory cytokines. TNF is one of the proinflammatory cytokines that has 
crucial role in the pathogenesis of CRS.  
 This case-controlled study aimed to identify the presence and associations of 
TNFα -1031 and TNFβ +252 gene polymorphisms between CRS and healthy controls 
as well as between CRSwNP and CRSsNP. Another purpose of this study was to 
investigate the associations of these genes polymorphisms with factors related to CRS. 
Forty eight CRS participants which comprised of 24 CRSsNP and 24 
CRSwNP participants together with 48 healthy controls were enrolled in this study. 
All DNA samples were collected from buccal mucosa and subsequently, genotyped 
for TNFα -1031 and TNFβ +252 genes by mean of polymerase chain reaction (PCR) 
and restriction fragment length polymorphisms (RFLP). The statistical analysis were 
carried out using Chi-square Test or Fisher’s exact test and multiple logistic 
regression to determine the associations of TNFα -1031 and TNFβ +252 gene 
polymorphisms in CRS with and without nasal polyps and risks of CRS. 
  Our findings confirmed the presence of TNFα -1031 gene polymorphisms in 
which the homozygous wild-type (TT) and heterozygous mutant-type (TC) were 
! xvi!
evenly distributed between CRS and healthy controls as well as in CRSsNP and 
CRSwNP. Homozygous mutant-type (CC) was absent in our population. Similarly, the 
wild-type allele (T) and mutant allele (C) revealed balance distributions. As for TNFβ 
+252 gene polymorphisms, the heterozygous mutant-type (AG) was identified to be 
more prevalent in comparison to homozygous wild-type (AA) and homozygous 
mutant-type (GG). The wild-type allele (A) and mutant-type allele (G) distributed 
uniformly. Statistical analysis of genotype and allele frequencies of TNFα -1031 and 
TNFβ +252 gene did not show any significant associations between CRS and healthy 
controls as well as between CRSwNP and CRSsNP. However, a significantly 
statistical difference of TNFα -1031 was observed in CRS participants with atopy (p-
value = 0.037) but not asthma and ASA intolerance. There were no significant 
associations of TNFβ +252 gene polymorphisms with factors related to CRS. 
In conclusion, the presence of TNFα -1031 and TNFβ +252 gene 
polymorphisms in current study did not render any significant associations between 
CRS and control as well as CRSsNP and CRSwNP. However, this study suggests that 
the presence of TNFα -1031 gene polymorphisms in CRS patients with atopy may be 
associated with increase susceptibility towards CRS.  
!
 
 
 
 
 
 
! 1!
CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Chronic rhinosinusitis 
1.1.1 Epidemiology 
Chronic rhinosinusitis (CRS) is one of the commonest upper respiratory tract 
diseases encountered by Otorhinolaryngologists as well as primary care physicians. 
The accurate prevalence of CRS worldwide is unknown. The Global Allergy and 
Asthma Network of Excellence (GA2LEN) conducted a survey based on European 
Position Paper on Sinusistis (EPOS) criteria in 19 centres in Europe involving 57128 
adults aged 15 to 75 years old. They found that the prevalence of CRS by EPOS 
criteria was 10.9%. This survey also mentioned that prevalence of self-reported 
physician-diagnosed CRS within these centres was substantially related to the EPOS 
diagnosed CRS (Hastan et al., 2011). Another survey done by the Korea National 
Health and Nutrition Examination Survey reported the overall prevalence of CRS was 
6.95% (Kim et al., 2011b). A comparative study in north of Scotland and Southern 
Caribbean found similar prevalence of CRS among patient who attended ORL clinics, 
which were 9.6% and 9.3%, respectively (Ahsan et al., 2004). 
The prevalence of CRS worldwide is more likely to be overestimated. It is 
because most of the researchers are focusing mainly on the clinical presentations of 
CRS without considering nasoendoscopic and Computed Tomography (CT) scan 
findings. However, studies showed there were poor associations between symptoms 
and nasoendoscopic or CT scan features among CRS patients (Stankiewicz and Chow, 
2002).  
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In contrary, the prevalence of nasal polyps seems to be underestimated. It is 
owing to the need of endoscopic examination to assess the existence of nasal polyps 
inside the nasal cavity. The prevalence of nasal polyps was estimated approximately 
2.7% in Sweden (Johansson et al., 2003). However, in an examination of autopsies, 
the occurrence of nasal polyps was found to much higher where nasal polyps was 
detected in 22 out of 69 autopsies (Larsen and Tos, 2004). 
CRS and nasal polyps were found to be more common among male than 
female in Sweden and Korea (Johansson et al., 2003; Kim et al., 2011b). However, a 
study among Canadians with CRS reported female is more susceptible towards CRS 
than male (Chen et al., 2003). The prevalence of CRS and nasal polyps were also 
higher with increasing age (Chen et al., 2003; Johansson et al., 2003).  
 Studies have shown that CRS has significant socioeconomic impact as well as 
impairment in patients’ quality of life. It has been estimated that the cost for ongoing 
treatment for CRS in the United States to be approximately USD2449 per patient but 
it has dropped markedly following endoscopic sinus surgery. However, the cost 
related to surgical procedure is still significantly expensive (Bhattacharyya et al., 
2011). Similarly, another study revealed the impact of CRS on insurance status, work 
absenteeism and resource use among race or ethnic group in United States (Soler et 
al., 2012).  
 
1.1.2 Definition and classification 
CRS is recognized as a chronic inflammatory disease affecting nasal and 
paranasal sinuses mucosa. The terminology of rhinosinusitis is being used instead of 
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sinusitis alone because rhinitis and sinusitis usually occur concurrently (Bachert et al., 
2003; Chan and Kuhn, 2009; Fokkens et al., 2012).  
The European Position Paper on Rhinosinusitis and Nasal Polyps 2012 
defined CRS as an inflammation involving nose and paranasal sinuses that occur 12 
weeks or more which characterised by two or more symptoms, one of which should 
be either nasal blockage, nasal congestion, or nasal discharge. Other symptoms 
include presence or absence of facial pain or reduction of smell. The diagnosis must 
be supported by either positive nasoendoscopic findings or CT scan changes. The 
endoscopic signs include presence of either nasal polyps or mucopurulent discharge 
or mucosal obstruction primarily in the middle meatus. Similarly, the positive CT 
scan findings include mucosal changes within the osteomeatal complex or sinuses 
(Fokkens et al., 2012).  
In European Position Paper on Rhinosinusitis and Nasal Polyps 2012, CRS is 
subclassified into two groups, which are chronic rhinosinusitis without nasal polyp 
(CRSsNP) and chronic rhinosinusitis with nasal polyp (CRSwNP) (Fokkens et al., 
2012). This classification indicates nasal polyps as one of the subset of CRS. It 
reflects that nasal polyps cannot occur without concurrent inflammation of nasal and 
paranasal sinuses mucosa. 
Both CRSsNP and CRSwNP present with similar symptoms but the diagnosis 
of nasal polyp are made based on nasoendoscopic findings in majority of cases unless 
the nasal polyp is very extensive and able to be visualised during anterior rhinoscopy. 
As for nasal polyp, it is further graded based on the endoscopic appearance (Lund, 
1995). According to this classification, Grade I is when the polyp is restricted to 
middle meatus, Grade II is when polyp is beyond middle meatus, while Grade III is 
massive polyp seen in the nasal cavity. 
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1.1.3 Factors associated with CRS 
Despite being one of the most prevalent diseases worldwide, the pathogenesis 
of CRSsNP and CRSwNP is still not well understood and appears to be multifactorial. 
Blockage of paranasal sinus ostia is thought to be the key to the inflammatory 
response in CRS. Mucosal oedema following inflammation results in obstruction of 
the paranasal sinuses ostia which eventually leads to retention of secretion and 
impaired sinus ventilation. This condition creates acidic and anaerobic environment 
within the sinuses. As a result, it enhances the immune reaction and infection of 
sinuses and thus promotes development of CRS (Naclerio and Gungor, 2001). 
The role of atopy in the development of CRS has been discussed extensively 
in the literature (Chen et al., 2003; Houser and Keen, 2008; Pearlman et al., 2009). In 
addition, the association between allergic rhinitis and CRS patients had also been 
described in previous studies (Houser and Keen, 2008; Kim et al., 2011b). 
Approximately half of the patients with CRS have positive skin prick test (Pearlman 
et al., 2009). The prevalence of positive skin prick test was reported even higher in 
CRS patient who failed medical treatment as compared to the general population 
(Shkoukani and Krouse, 2013). These findings suggest that allergic inflammation of 
nasal mucosa plays a vital role in the development of CRS. It owes to the swelling of 
nasal mucosa which leads to narrowing of the sinus ostia and retention of mucous 
within sinuses.  
Asthma has been implicated as one of the factors that contribute to the 
susceptibility towards development of CRS. Due to awareness of ‘one airway, one 
disease’ concept, many studies have been conducted to observe the relationship 
between CRS and asthma (Chen et al., 2003; Johansson et al., 2003). GA2LEN 
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survey in 12 European countries showed that there was a high preponderance of 
asthma in CRS patients with the odd ratio of 3.47 and the association was even 
stronger in patients who had concurrent allergic rhinitis in which the odd ratio was 
estimated to be 11.85 (Jarvis et al., 2012). A study on 553 Japanese had shown that 
the prevalence of CRS in asthmatic patients was 23.1% (Yoshimura et al., 2001). 
Moreover, the incidence of nasal polyps is also likely to occur in asthmatic than non 
asthmatic patients (Pearlman et al., 2009). These findings suggest that the upper and 
lower airway diseases form an integrated airway syndrome model because the nasal, 
paranasal sinuses and bronchus are a continuous structures that are lined by ciliated 
columnar epithelium (Vinuya, 2002; Togias, 2003).  
Aspirin sensitivity has been recognised as one of the associated factors in 
nasal polyps. Previous study demonstrated 36.0% of patients with aspirin intolerance 
had concurrent nasal polyps (Settipane, 1996). However, more recent studies reported 
contradicting data regarding this association among Skovde population in Sweden 
(Johansson et al., 2003). Another study among Chinese population also documented 
low prevalence of non steroidal anti inflammatory drugs intolerance in CRS patients 
(Lu et al., 2014). The possible explanation for this poor association is the rarity of 
aspirin usage in clinical practice nowadays. Hence, the association between aspirin 
intolerance and CRS may be underestimated in many of the studies.  
Many studies have pointed smoking as another important predisposing factor 
for the development of CRS. A number of studies corroborated strong association of 
cigarette smoking among CRS and nasal polyps patients (Chen et al., 2003; Houser 
and Keen, 2008; Hastan et al., 2011). The prevalence of CRS was reported to be 
higher in not only among active smokers but also in passive smokers (Reh et al., 
2012). Cigarette smoke, either actively or passively inhaled is thought to cause 
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alterations in respiratory epithelium which subsequently impair the mucociliary 
activity along the respiratory tract. However, a systematic review on the effects of 
smoking and CRS found out that there might be individual susceptibility in the 
development of CRS among smokers (Tamashiro et al., 2009).  
Genetically determined susceptibility undoubtly plays an important role in the 
development of CRS. Supportive evidence for genetic basis of nasal polyp was 
proposed by Qu et al. (2007) where they found that first degree and second degree 
relatives have higher chances to develop nasal polyp as compared to control group. 
Similarly, it has been reported identical twins have similar chances to develop nasal 
polyps despite different social lifestyles (Drake-Lee, 1992). At present, some efforts 
have been focusing on genetic studies of both CRSsNP and CRSwNP which are 
believed to have promising correlation that might contribute to the pathogenesis of 
this disease (Hsu et al., 2013). 
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Figure 1.1: Inflammatory process in CRSsNP and CRSwNP. ECM, extracellular 
matrix; ECP, eosinophilic cationic protein; FoxP3, forkhead box P3; IFN, interferon; 
IL, interleukin; MMP, matrix metalloproteinase; MMR, macrophage mannose 
receptor; T-bet, T-box transcription factor; TGF, transforming growth factor; Th, T 
helper cell; TIMP, tissue inhibitor of matrix metalloproteinase; TNF, tumour necrosis 
factor; Treg, T regulatory cell. 
(Adapted from Huvenne et al (2009). Chronic Rhinosinusitis With and Without Nasal 
Polyps: What Is the Difference? Curr Allergy Asthma Rep, 9(3), 213-220.) 
216  I  Sinusitis
 Figure 1 .  Chronic rhinosinusitis without ( A ) and with ( B ) nasal polyps. CRSsNP—chronic rhinosinusitis without nasal polyps; CRSwNP—chronic 
rhinosinusitis with nasal polyps; ECM—extracellular matrix; ECP—eosinophil cationic protein; FoxP3—forkhead box P3; IFN—interferon; 
IL—interleukin; MMP—matrix metalloproteinase; MMR—macrophage mannose receptor; T-bet—T-box transcription factor; TGF—transforming 
growth factor; Th—T-helper cell; TIMP—tissue inhibitor of matrix metalloproteinase; TNF—tumor necrosis factor; Treg—T-regulatory cell. 
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 Figure 1 .  Chronic rhinosinusitis without ( A ) and with ( B ) nasal polyps. CRSsNP—chronic rhinosinusitis without nasal polyps; CRSwNP—chronic 
rhinosinusitis with nasal polyps; ECM—extracellular matrix; ECP—eosinophil cationic protein; FoxP3—forkhe d box P3; IFN—interferon; 
IL—interleukin; MMP—matrix metalloproteinase; MMR—macrophage mannose re eptor; T-bet—T-box transcription factor; TGF—transforming 
growth factor; Th—T-helper cell; TIMP—tissue inhibito  f matrix metallopr teinase; T F—tumor necrosis factor; Treg—T-regulatory cell. 
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1.2 Molecular biology of CRS 
1.2.1 Inflammatory process in CRS 
Inhalation of noxious substances such as bacteria, viruses, fungi and allergens 
result in alteration of respiratory epithelium. This mucosal irritation of airway 
epithelium triggers the initial mucosal event of inflammatory process in CRS. 
Subsequently, T lymphocytes are activated in response to inflammation both in 
CRSsNP and CRSwNP (Figure 1.1). However, the distinct molecular biologic event 
in CRSsNP and CRSwNP suggest that these two conditions have separate entities. 
The differences between CRSsNP and CRSwNP are summarized in Table 1.1. 
T helper 1 (Th1) and T helper 2 (Th2) cells recognise major histocompatibility 
complex Class II (MHC II) that bind on cell surface of pathogen following 
inflammation. CRSsNP is characterised by Th1 as compared to CRSwNP which 
mainly involves Th2 polarisation (Huvenne et al., 2009; Crombruggen et al., 2011; 
Eloy et al., 2011). Th1 and Th2 cells commitments are specified by T box 
transcription factor (Tbet) and GATA binding protein (GATA-3), respectively. 
Another subpopulation of T cell, regulatory T cell (Treg) which is characterised by 
forkhead box protein 3 (FoxP3) responsible in modulating inflammatory process in 
chronic illnesses. It has been postulated that Treg can migrate to the site of 
inflammation and regulate the Th1 and Th2 cells (Umetsu and DeKruyff, 2006). 
Inflammation mediated by Th2 is the main feature in CRSwNP (Ramanathan 
et al., 2008). Th2 cells stimulate the release of cytokines mainly IL5. These cytokines 
promote the recruitment of eosinophils and release of eosinophilic cationic protein 
(ECP). ECP results in epithelial damage, oedema formation and albumin deposition. 
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Table 1.1: Immunobiologic phenomena and histological features of CRSsNP and 
CRSwNP 
 CRSsNP CRSwNP 
T cell profile Th1  Th2 
Inflammatory cell profile Mainly neutrophils, 
↓eosinophils and mast 
cells 
Mainly eosinophils, ↓B 
and T cell 
Proinflammatory cytokines TNFα, TNFβ, IL1β, IFNγ IL4, IL13, TNFα 
Endothelial adhesion 
molecules 
↑ICAM-1 ↑VCAM-1 
Transcription factors Adequate FoxP3, ↑Tbet ↓FoxP3, ↑GATA-3 
Extracellular matrix 
proteins 
↑MMP-9, ↑TIMP-1 ↑MMP-9, ↓ TIMP-1 
Histological features Limited subepithelial 
oedema, prominent 
collagen deposition and 
fibrosis 
Epithelial damage, tissue 
oedema, pseudocyst 
formation containing 
albumin, thickened 
basement membrane, less 
fibrosis 
↑, increase; ↓, decrease 
 Abundance of IgE antibodies to Staphylococcus aureus are found in CRSwNP 
as compared than in CRSsNP patients suggest that nasal polyps involve eosinophilic 
inflammation (Bachert et al., 2001). Thus, it hypothesises the potential effects of 
superantigen in the pathogenesis of CRSwNP (Wang et al., 2008). Staphylococcal 
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superantigens activate both T and B cells with multiclonal IgE formation, thus 
eliciting massive inflammatory reaction in CRSwNP. In comparison, neutrophilic 
inflammation is more prominent in CRSsNP that shows increased Th1 cells 
polarisation. 
CRSwNP is also associated with significant down regulation of forkhead box 
P3 (FoxP3) (Bruaene et al., 2008). Reduction in FoxP3 level signifies the deficiency 
in Treg cells function in patients with CRSwNP and thus, results in low transforming 
growth factor β1 (TGFβ1) (Sejima et al., 2012; Chuan et al., 2013). TGFβ1 is 
important in controlling initiation and resolution of inflammatory responses. Lack of 
the TGFβ1 contributes to massive oedema formation and deficient of collagen 
formation in CRSwNP. On the other hand, increase TGFβ1 levels and adequate 
FoxP3 expression in CRSsNP may explain the excessive collagen deposition and 
fibrosis formation in this condition with minimal tissue oedema. 
The remodeling process in CRS is characterised by alteration in the extracellular 
matrix (ECM) which is also played by transforming growth factor β1 (TGFβ1). It 
stimulates the balance between matrix metalloproteinase-9 (MMP-9) and tissue 
inhibitor of matrix metalloproteinase-1 (TIMP-1).  TIMP-1 plays a role in preventing 
enzymatic breakdown of ECM. It has been demonstrated that MMP-9 and TIMP-1 are 
upregulated in CRSsNP while in CRSwNP only MMP-9 is upregulated but not TIMP-
1 (Watelet et al., 2004). The imbalance between MMP-9 and TIMP-1 in CRSwNP 
leads to ECM destruction and albumin accumulation which subsequently results in 
tissue oedema and pseudocyst formation. These distinguished immunological features 
showed that CRSwNP exhibit more severe inflammatory process than CRSsNP.  
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 Recent literature demonstrated different inflammatory pattern among Asian 
patients with CRSwNP, whereby Th17 cells predominate in this population as 
compared to whites, which amplifying neutrophilic inflammation rather than 
eosinophilic (Zhang et al., 2008). Similarly, another study in Malaysia also reported 
increase prevalence of neutrophilic nasal polyps based on histopathological findings 
(Tikaram and Prepageran, 2013).  
 
1.2.2 Proinflammatory cytokines in CRS 
The presence of proinflammatory cytokines has been advocated in the 
development of CRS. Although the precise molecular mechanisms by which the 
proinflammatory cytokines can induce mucosal response in CRS is still not well 
established, there are some evidences that show these cytokines may play roles in the 
disease process (Min and Lee, 2000; Perić et al., 2010; Sejima et al., 2012).  
 The initial event that triggers the inflammatory process in CRSsNP is the 
bacterial colonisation at the nasal and paranasal sinuses mucosa. It has been shown 
that the predominant inflammatory cells being secreted are neutrophils, followed by 
little contributions from macrophages, mast cells, eosinophils and basophils which are 
capable of releasing cytokines mainly tumour necrosis factor particularly tumour 
necrosis factor alpha (TNFα) and less commonly tumour necrosis factor beta (TNFβ) 
as well as interleukin 1 beta (IL1β) and interferon gamma (IFNγ) (Stierna, 2001; 
Pawankar and Nonaka, 2007). These cytokines upregulate the endothelial adhesion 
molecule namely intracellular cell adhesion molecule-1 (ICAM-1) (Eloy et al., 2011). 
Consequently, there is influx of inflammatory cells in chronically inflamed tissue, 
thus enhancing the inflammatory response.  
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 On the other hand, the mechanisms promoting the accumulation of eosinophils 
in CRSwNP has been attributed by vascular cell adhesion molecule-1 (VCAM-1) 
(Hamilos, 2000; Bernstein, 2001; Pawankar and Nonaka, 2007). VCAM-1 
participates in eosinophilic recruitment on nasal and paranasal endothelium. Activated 
mast cells facilitates the release of proinflammatory cytokines such as interleukin 4 
(IL4), interleukin 13 (IL13) and TNFα (Pawankar and Nonaka, 2007; Otto and 
Wenzel, 2008). The activated mast cells also stimulate the upregulation of eotaxin and 
regulate on activation normal T cell expressed and secreted (RANTES), which 
subsequently promotes further infiltration of eosinophils to the tissue (Bernstein, 
2005). The upregulation of eosinophils in CRSwNP suggests that allergy and asthma 
might be implicated in the pathogenesis of CRSwNP. 
 
1.2.3 Role of TNF as proinflammatory cytokines in CRS 
 Although various cytokines have been proven to play pivotal roles in 
pathogenesis of CRS, this study concentrated on area relating to tumour necrosis 
factor (TNF). TNF was first described by Carswell EA et al in 1975 where they found 
that endotoxin-induced serum in mice release a substance that can cause necrosis in 
tumour tissues (Carswell et al., 1975). However, only in 1985, Aggarwal et al. (1985) 
was the first who defined two distinct types of TNF, which are TNFα and 
lymphotoxin or also known as TNFβ. TNFα is derived from macrophages with 
molecular mass of 17 kDa while TNFβ is produced by lymphocytes with molecular 
mass of 20 kDa (Aggarwal et al., 2012). Both have 50 percent amino acids sequence 
identity, thus they share many similar functions. 
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 Various biological functions of TNF have been described in the literatures. 
TNF is thought to promote inflammation by releasing cyclooxygenase 2. Both TNFα 
and TNFβ share same receptors eventhough they show discrete binding affinity to the 
receptors. Once the TNF molecules bind to their receptors, they induce signaling 
interaction within the target cells. TNF display two different receptors, which are 
tumour necrosis factor receptor 1 (TNFR1) and tumour necrosis factor receptor 2 
(TNFR2). TNFR1 are found in most of cells in human, in contrast, TNFR2 are 
confined to cells of immune system, endothelial cells and nervous cells (Aggarwal et 
al., 2012). TNFα exhibit both soluble and transmembrane ligands while TNFβ 
express as soluble ligands only.  
The cell signaling is important in controlling the inflammatory process. In 
physiological state, TNF production is important for normal response towards 
inflammation. However, excessive accumulation of TNF in human body can be 
harmful. In some cases, TNF signaling promotes lymphocytes apoptosis in response 
to infection, while in certain cases, it stimulates lymphocytes proliferations to combat 
the inflammation. Because of contradicting role of TNF, it is essential to control the 
balance of this cell signaling. Once the TNF signaling lost its control, the 
inflammation overwhelm and resulting in serious diseases (Goodsell, 2006).  
 
1.3 Single nucleotide polymorphisms (SNPs) 
1.3.1 Definition 
 SNPs are one of the most common polymorphisms seen in human genome 
(Marian, 2010).  SNPs are defined as genetic variation in deoxyribonucleic acid 
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(DNA) where a single nucleotide is being replaced by another, either by substitution 
or deletion as depicted in Figure 1.2 (Brooks, 2003). They exist in normal population 
and this allele variant has a frequency of one percent or greater. SNPs differ from 
mutation in which mutation occurs in less than one percent of the population and they 
cause more serious manifestation of diseases (Crawford and Nickerson, 2005). 
 The polymorphism in the DNA sequence is known as allele. SNP can be 
assigned as major or minor allele depending on its occurrence in the observed 
population. There are variations of SNP allele frequencies among different 
populations. Haplotype is referred to allelic combination because human is diploid 
(each chromosome is carried from mother and father). A pair of haplotypes contribute 
to several genotypes in SNP which are homozygous for major allele (homozygous 
wild-type), heterozygous (heterozygous mutant-type) and homozygous for minor 
allele (homozygous mutant-type) (Brooks, 2003; Guerra and Yu, 2005). The 
dominant allele is known as wild-type allele while rare allele recognised as mutant 
allele. 
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Figure 1.2: An example of SNPs. The polymorphism is denoted by substitution of 
nucleotide A to nucleotide G. A, adenosine; C, cytosine; G, guanine; T, thymine. 
(Adapted from https://www.celera.com/celera/cdx_discover). 
 
1.3.2 SNPs and human diseases 
The association of SNPs and human disease is complex. The genetic 
pathogenesis of certain common diseases is still not well understood and further 
research is warranted to identify the genetic architecture of these diseases. 
Approximately 6 million human SNPs are listed in the database of single nucleotide 
polymorphisms (dbSNP) (Wheeler et al., 2004). It has been estimated that SNPs 
manifest about once every 1000 bases in human DNA sequence (Guerra and Yu, 
2005). Identification of large number of SNPs across human genome has brought the 
attention of the genetic association studies with common human diseases in a 
population because common population shares similar genetic variances. This 
database has contributed to a very useful information in the field of research.  
! 16!
Perhaps common diseases that exist in an observed population are resulting from 
interaction of multiple genes and polymorphisms eventhough most of them exert little 
effects (Li et al., 2012). Unlike single-gene disorders, SNPs result from the complex 
interplay between genetic and environmental factors (Brooks, 2003). The studies of 
SNPs have taken into account the genotype distributions and allele frequencies 
between cases (people who carry the desired disease to be studied) and controls 
(people who do not have the disease) (Fareed and Afzal, 2013).  
In the past, family-based study is more popular in genetic association study. 
Nowadays, researchers are more interested in SNPs. However, this case-controlled 
study needs large number of population to determine the optimal association of SNPs 
and diseases in the population. It is also difficult to differentiate the association of 
SNPs with specific diseases because many SNPs are also related with other diseases. 
Apart from that, the researchers need to choose which gene or promoter region that 
are related to the disease (Bell, 2002; Crawford and Nickerson, 2005).  
Despite the disadvantages mentioned above, SNPs still have value in genetic 
association studies of common diseases in certain population. This owes to the 
discovery of vast number of potential SNPs across human genome and it is more cost 
efficient as compared to other genetic studies (Cordell and Clayton, 2005). The 
alteration in genetic sequence are inherited from one generation to subsequent 
generations, thus studies on SNPs could be easier to be identified in the population. 
SNPs has become an effective tools in the genetic field because polymorphisms are 
likely to be involved in disease pathogenesis as well as targets for therapeutic 
interventions (Sripichai and Fucharoen, 2007). 
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1.4 Tumour necrosis factor (TNF) gene polymorphisms 
1.4.1 TNF gene 
The position of TNF gene has been established in the short arm of 
chromosome 6 which occupying the highly polymorphic domain of Class III major 
histocompatibility complex (MHC). Several polymorphic microsatellites have been 
recognized along this region, namely TNF a, b, c, d, e and f (Figure 1.3) (Hajeer and 
Hutchinson, 2000). Perhaps the involvement of TNF gene in various immune 
responses is because of its proximity to HLA gene in chromosome 6. Literature has 
shown that there is a linkage equilibrium between TNF microsatellites and HLA gene 
(Hajeer and Hutchinson, 2001). There are plentiful SNPs that have been classified in 
the TNFα promoter region at position (relative to transcription start region) -1031, -
863, -857, -851, -419, -376, -308, -238, -162 and -49 (Hajeer and Hutchinson, 2001; 
Elahi et al., 2009).  
TNFα -1031 is one of the polymorphisms identified. Numerous studies have 
been carried out to determine the association between this polymorphic site and 
various inflammatory diseases. TNFα -1031 is a thymine (T) to cytosine (C) 
substitution. TNFα gene is postulated to be associated with increase in transcriptional 
activity and elevated circulating TNFα levels (Abraham and Kroeger, 1999; 
Majetschak et al., 1999). This finding indicates that TNFα might be a beneficial 
genetic marker in future research especially in the area of inflammatory diseases. 
 TNFβ gene locus lies within first intron at position +252 in chromosome 6. 
The polymorphism in this region results from substitution of adenosine (A) to guanine 
(G). Evidence has demonstrated that TNFβ +252G allele is related with higher 
production of TNFβ expression at mRNA and protein assays. Another finding showed 
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that TNFβ +252A allele is correlated with elevated TNFβ as well as TNFα 
production (Messer et al., 1991). 
 
 
Figure 1.3: TNF gene locus on chromosome 6 depicting the position of microsatellites 
and SNPs.  
(Adapted from Hajeer, A. H. & Hutchinson, I. V. (2001). Influence of TNF alpha 
gene polymorphisms on TNF alpha production and disease. Hum Immunol, 62, 1191-
1199). 
 
1.4.2 SNP of TNF gene and human diseases 
Numerous proinflammatory cytokine gene polymorphisms have been 
extensively studied in various infectious and inflammatory conditions as well as 
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cancer. The influence of TNF gene polymorphisms in many inflammatory diseases 
has been addressed in the literatures (Qidwai and Khan, 2011). Majority of the studies 
are focusing on whether these gene polymorphisms involve in the pathogenesis as 
well as prognosis of human diseases.  
TNF gene composed of multiple sites of polymorphisms and these 
polymorphisms have shown to predispose individuals to certain diseases. Hence, the 
identification of such polymorphisms might suggest the role of TNF gene in 
establishing early diagnosis as well as treatment plan. The TNF gene polymorphisms 
have been associated with many chronic inflammatory conditions including 
rheumatoid arthritis, inflammatory bowel disease and hepatitis B virus infection 
(Sashio et al., 2002; Cuenca et al., 2003; Li et al., 2006; Romero et al., 2008; Al-
Rayes et al., 2011). It has becomes evidence that TNFα antagonists are effective in 
the treatment for rheumatoid arthritis. Etanercept and Infliximab demonstrated 
significant improvement of the symptoms in affected patients (Seymour et al., 2001). 
 
1.4.3 Association of TNF gene polymorphisms with CRSsNP and CRSwNP 
At present, studies on association of TNF gene polymorphisms and CRS 
render rather ambiguous results. Nonetheless, ongoing studies on this gene are still of 
interest because it becomes increasingly apparent that the presence of these gene 
polymorphisms has a potential role in the therapeutic strategies as well as preventive 
measures. 
Erbek et al. (2007) detected the role of TNFα (-238 and -308) as well as 
interleukin 1α (IL1α) and interleukin 1β (IL1β) gene polymorphisms in the 
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development of CRSwNP among Turkish population. Similar study in Canada 
identified the association of IL1α gene polymorphism with CRS. However, they 
unable to replicate the associations between TNFα and IL1β gene polymorphisms 
towards CRS susceptibility (Endam et al., 2010).  
 Bernstein et al. (2009) genotyped 14 cytokines gene polymorphisms in 
CRSwNP patients and controls. TNFα polymorphisms showed statistically significant 
relationships among Caucasian population. In this study, no significant difference 
between CRSwNP and controls were reported for these cytokine polymorphisms 
except TNFα gene.  SNPs in TNFα were also investigated in CRS and control among 
Turkish and Hungarian populations. They found that the presence of polymorphisms 
in TNFα gene might increase the risk of CRS development (Batikhan et al., 2010; 
Szabo et al., 2013). 
The studies of SNPs have given different associations in different populations. 
TNFα and TNFβ gene polymorphisms were investigated among Japanese with CRS. 
TNFα polymorphisms have demonstrated no significant difference between CRS 
patients and healthy individuals. In contrast, significant association was established 
between allele frequency for TNFβ polymorphism (Takeuchi et al., 2000). Another 
study was carried out among patient who suffered from CRSwNP in Mexico. The 
results of this study showed that there was no significant association between TNFα 
polymorphisms and susceptibility towards CRSwNP (Fajardo-Dolci et al., 2006). 
The exact mechanism on how TNF affects the inflammatory reaction in CRS 
is still controversial. It is still unknown whether TNF causes severe inflammatory 
reaction or the severity of the inflammatory reaction produce more TNF in CRS. With 
respect to CRSwNP, the expression of TNFα gene was detected in nasal polyp tissue 
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but not in normal mucosa suggesting the role of this proinflammatory cytokines in the 
pathogenesis of this disease (Finotto et al., 1994). In addition, literature did 
demonstrate the improvement of inflammatory reaction and mucus production after 
administration of TNFα antagonist in lipopolysaccharide-induced rhinosinusitis mice 
(Kim et al., 2011a). Given the evidence mentioned above, we hypothesised that there 
might be association between TNF gene polymorphisms and chronic rhinosinusitis 
with and without nasal polyps. 
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CHAPTER 2: OBJECTIVES 
 
2.1 General objective 
• To determine the association of TNF gene polymorphism in chronic 
rhinosinusitis with and without nasal polyps 
 
2.2 Specific objectives 
i. To identify the presence of TNF gene polymorphism in chronic rhinosinusitis and 
control 
ii. To identify the presence of TNF gene polymorphism in chronic rhinosinusitis 
patient with and without nasal polyps 
iii. To determine the association of TNF gene polymorphism among chronic 
rhinosinusitis and healthy control 
iv. To determine the association of TNF gene polymorphism among chronic 
rhinosinusitis with and without nasal polyps 
v. To determine the association between TNF gene polymorphism with factors 
related to CRS 
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CHAPTER 3: METHODOLOGY 
 
3.1 Hypothesis 
 
Alternative hypothesis: There is association of TNF gene polymorphisms in chronic 
rhinosinusitis with and without nasal polyps. 
 
3.2 Study design 
This is a case-controlled study to determine the association between TNF gene 
polymorphisms in chronic rhinosinusitis with and without nasal polyps.  
 
3.3 Study population 
All participants were above 18 years old. Cases were recruited from patients 
who attended Otorhinolaryngology - Head and Neck (ORL-HNS) Clinic, Hospital 
Universiti Sains Malaysia (USM) while controls were recruited from healthy 
individual that came from same district as cases. 
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3.4 Inclusion and exclusion criteria  
3.4.1 Inclusion criteria 
3.4.1.1 Inclusion criteria for cases 
• Participants who were confirmed to have chronic rhinosinusitis with or without 
nasal polyps based on history and physical examination 
• Nasal polyps were confirmed by nasoendoscopy 
3.4.1.2 Inclusion criteria for controls 
• Healthy individuals and not known to have sinonasal disease 
• Selected from the same district area as cases 
 
3.4.2 Exclusion criteria 
3.4.2.1 Exclusion criteria for cases 
• Participants whom were known to have chronic rhinosinusitis secondary to 
other diseases such as cystic fibrosis, Kartagener’s syndrome or Young syndrome 
• Patient with antrochoanal polyps, inverted papilloma or sinonasal malignancy  
3.4.2.2 Exclusion criteria for controls 
• Participants who are blood-related with the cases 
• Participants who are known to have allergy 
 
 
